StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) income statement

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new financial ratios

See a number that looks wrong?